5,200,000 Shares CONATUS PHARMACEUTICALS INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • May 11th, 2017 • Conatus Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Conatus Pharmaceuticals Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”) an aggregate of 5,200,000 shares (the “Firm Shares”) of the common stock, par value $0.0001 per share, of the Company (“Common Stock”). The Company also proposes to sell to the several Underwriters, at the option of the Underwriters, up to an additional 780,000 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
CONATUS PHARMACEUTICALS INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 11th, 2017 • Conatus Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This STOCK PURCHASE AGREEMENT (this “Agreement”) is dated as of May 10, 2017 by and among Conatus Pharmaceuticals Inc., a Delaware corporation (the “Company”), and the stockholders of the Company listed on Schedule I to this Agreement (each a “Holder” and collectively, the “Holders”).
